Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -48.66x is 82% above its 5-year average of -274.62x, near the low end of its 5-year range (-2811.63x–8521.28x).
106.68% below its 12-month average of 728.89x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2024 (2024-06-30): -1387.82x.
INTEREST COVERAGE RATIO
-48.66x
INTEREST COVERAGE RATIO AVG TTM
728.89x
INTEREST COVERAGE RATIO AVG 3Y
267.89x
INTEREST COVERAGE RATIO AVG 5Y
-274.62x
INTEREST COVERAGE RATIO AVG 10Y
-25.74x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-106.68%
CURRENT VS 3Y AVG
-118.16%
CURRENT VS 5Y AVG
+82.28%
CURRENT VS 10Y AVG
-89.04%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-740.41%
vs the sector median at left
ProQR Therapeutics N.V.
Market Cap
$173.23M
Interest Coverage Ratio
-48.66x
TTM Avg
728.89x
3Y Avg
267.89x
5Y Avg
-274.62x
Market Cap
$172.83M
Interest Coverage Ratio
-36.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$172.49M
Interest Coverage Ratio
-74.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$175.21M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$171.14M
Interest Coverage Ratio
N/A
TTM Avg
8.41x
3Y Avg
7.29x
5Y Avg
7.29x
Market Cap
$169.76M
Interest Coverage Ratio
-38.13x
TTM Avg
21.71x
3Y Avg
21.71x
5Y Avg
21.71x
Market Cap
$176.67M
Interest Coverage Ratio
-2.21x
TTM Avg
15.94x
3Y Avg
15.94x
5Y Avg
15.94x
Market Cap
$165.88M
Interest Coverage Ratio
2.28x
TTM Avg
2.28x
3Y Avg
2.28x
5Y Avg
2.28x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ProQR Therapeutics N.V. (PRQR) | $173.23M | -48.66x | 728.89x | 267.89x | -274.62x |
| Precision BioSciences, Inc. (DTIL)vs › | $172.83M | -36.67x | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $172.49M | -74.29x | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $175.21M | N/A | N/A | N/A | N/A |
| Organogenesis Holdings Inc. (ORGO)vs › | $171.14M | N/A | 8.41x | 7.29x | 7.29x |
| MediWound Ltd. (MDWD)vs › | $169.76M | -38.13x | 21.71x | 21.71x | 21.71x |
| Journey Medical Corporation (DERM)vs › | $176.67M | -2.21x | 15.94x | 15.94x | 15.94x |
| Nkarta, Inc. (NKTX)vs › | $169.20M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.88M | 2.28x | 2.28x | 2.28x | 2.28x |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $182.12M | N/A | 14.48x | 14.48x | 14.48x |
Interest Coverage
-48.7x
Debt/Equity
0.17
Current Ratio
3.49
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-06-30 | -1387.82x |
| 2024-03-31 | -2811.63x |
| 2023-12-31 | 22.65x |
| 2023-09-30 | -700.04x |
| 2023-06-30 | 8521.28x |
| 2023-03-31 | -17.26x |
| 2022-12-31 | -10.15x |
| 2022-03-31 | -20.73x |
| 2021-12-31 | -912.00x |
| 2021-06-30 | -5.36x |
| 2021-03-31 | -41.31x |
| 2020-12-31 | -729.19x |
| 2020-09-30 | -5.83x |
| 2020-06-30 | -4.82x |
| 2019-12-31 | -10.50x |
| 2019-06-30 | -22.29x |
| 2018-12-31 | -88.01x |
| 2018-09-30 | -79.97x |
| 2018-03-31 | -11.48x |
| 2017-12-31 | -21.20x |
| 2017-09-30 | -11.12x |
| 2017-06-30 | -8.60x |
| 2017-03-31 | -18.51x |
| 2016-12-31 | -38.27x |
| 2016-09-30 | -38.87x |
| 2016-03-31 | -6.35x |
| 2015-09-30 | -125.34x |
| 2015-06-30 | -2.98x |
| 2014-03-31 | -29.46x |
| 2013-12-31 | -42.50x |
